Â鶹ÊÓƵ

From the SHA:

As of JUNE 24, second dose eligibility is open to all residents 12+.ÌýÌýYou can receive your second dose 28 days from your first dose.

Vaccine Inventory Continues to Increase

The SHA is anticipating that with additional vaccine allotments arriving weekly there will be enough COVID-19 vaccine available to support the administration of all outstanding second doses by mid-July though vaccine type available will be based on vaccines delivered. Residents are urged take advantage of one of the many options available for immunization: booked appointments, drive-thru and walk-in clinics, pop-up clinics, and participating pharmacies.

Effective immediately, the SHA has over 47,000 booked appointments available for first and second dose immunizations at clinics throughout the province.

Vaccine Eligibility

First Dose Eligibility: All residents aged 12 and older.
Second Dose Eligibility: All residents, a minimum of 28 days after their first dose.

YOU CANNOT “LOSE" ELIGIBILITY. ONCE YOU BECOME ELIGIBLE FOR IMMUNIZATION, YOU REMAIN ELIGIBLE.
This applies to both first and second dose immunizations.

Vaccines are available to all residents aged 12 and older. Note that only the Pfizer vaccine has been approved for use with residents aged 12 to 17.

For additional information on COVID-19 vaccines and immunization, visitÌý

Where to Get Immunized

Saskatchewan residents have multiple options for receiving first and second doses of COVID-19 vaccine when eligible.

To be immunized, and for the most up-to-date information on available clinic locations and hours the following resources are available:

• Drop in to one of our mobile or pop-up clinics when we announce one in your community.
• See the full list of drive-thru and walk-in clinics and hours atÌý.
• Book an appointment online 24/7 atÌý.
• Call 1-833-SASKVAX (1-833-727-5829) to book your appointment, 7 days a week, 8:00 a.m. to 9:00 p.m.
• Visit your local pharmacy. For a list of participating pharmacies, including vaccine brands available, visitÌý Ìý.

Changing Vaccine Brands Between First & Second Doses
In response toÌý, Saskatchewan's clinical experts have recommended that individuals in Saskatchewan who received AstraZeneca as their first dose be offered the choice of receiving AstraZeneca or an mRNA vaccine (Pfizer/Moderna) as their second dose.

Where AstraZeneca is on hand, residents who had it as a first dose will be offered the choice of either AstraZeneca or an mRNA vaccine for their second dose. AstraZeneca remains a safe vaccine and two doses are effective against severe disease and hospitalization.

Individuals who have received two doses of any COVID-19 vaccine approved for use in Canada should be considered protected and do not require an additional vaccine at this time.

mRNA Vaccines are Interchangeable
Residents who received Pfizer or Moderna as their first dose should take whichever of those two vaccines that is available to them for their second dose, rather than waiting for the same brand of vaccine. The Pfizer brand remains the only one approved for use in children ages 12-17.

A vaccine is only approved by Health Canada if it is safe, it works, it meets manufacturing standards, and the benefits outweigh any risks.

Ìý